Dan Combs1, Safal Shetty2, Sairam Parthasarathy2. 1. Arizona Respiratory Center, University of Arizona, Tucson, AZ ; Department of Pediatrics, University of Arizona, Tucson, AZ. 2. Arizona Respiratory Center, University of Arizona, Tucson, AZ ; Division of Pulmonary, Critical Care, Allergy and Sleep Medicine, Department of Medicine of University of Arizona, Tucson, AZ.
Abstract
RATIONALE: Positive airway pressure therapy for hypoventilation syndromes can significantly improve health-related quality of life (HR-QOL), healthcare costs, and even mortality. The sleep-disordered breathing in such individuals are quite complex and require sophisticated devices with algorithms that are designed to accurately detect and effectively treat respiratory events that includes hypoventilation, upper airway obstruction, lower airway obstruction, central apneas and central hypopneas and reduce the work of breathing while maintaining breathing comfort. OBJECTIVES: The therapeutic physiological rationale for the various advanced PAP modalities and the details about the principles of operation and technology implementation are provided here. CONCLUSIONS: The physiological rationale for advanced PAP modalities is sound considering the complexity of sleep-disordered breathing in patients with hypoventilation syndromes. Although such devices are increasingly used in clinical practice, the supporting clinical evidence - specifically comparative-effectiveness studies in real-life conditions -- needs to be performed. Moreover, there is much opportunity for further refining these devices that include the ability of the device to reliably monitor gas-exchange, sleep-wakefulness state, and for reducing variability in device efficacy due to provider-selected device-settings.
RATIONALE: Positive airway pressure therapy for hypoventilation syndromes can significantly improve health-related quality of life (HR-QOL), healthcare costs, and even mortality. The sleep-disordered breathing in such individuals are quite complex and require sophisticated devices with algorithms that are designed to accurately detect and effectively treat respiratory events that includes hypoventilation, upper airway obstruction, lower airway obstruction, central apneas and central hypopneas and reduce the work of breathing while maintaining breathing comfort. OBJECTIVES: The therapeutic physiological rationale for the various advanced PAP modalities and the details about the principles of operation and technology implementation are provided here. CONCLUSIONS: The physiological rationale for advanced PAP modalities is sound considering the complexity of sleep-disordered breathing in patients with hypoventilation syndromes. Although such devices are increasingly used in clinical practice, the supporting clinical evidence - specifically comparative-effectiveness studies in real-life conditions -- needs to be performed. Moreover, there is much opportunity for further refining these devices that include the ability of the device to reliably monitor gas-exchange, sleep-wakefulness state, and for reducing variability in device efficacy due to provider-selected device-settings.
Authors: Patrick Brian Murphy; Craig Davidson; Matthew David Hind; Anita Simonds; Adrian J Williams; Nicholas S Hopkinson; John Moxham; Michael Polkey; Nicholas Hart Journal: Thorax Date: 2012-03-01 Impact factor: 9.139
Authors: A Koutsoukou; N Koulouris; B Bekos; C Sotiropoulou; E Kosmas; K Papadima; C Roussos Journal: Acta Anaesthesiol Scand Date: 2004-10 Impact factor: 2.105
Authors: R G Miller; C E Jackson; E J Kasarskis; J D England; D Forshew; W Johnston; S Kalra; J S Katz; H Mitsumoto; J Rosenfeld; C Shoesmith; M J Strong; S C Woolley Journal: Neurology Date: 2009-10-13 Impact factor: 9.910
Authors: Julia L Kelly; Jay Jaye; Rachel E Pickersgill; Michelle Chatwin; Mary J Morrell; Anita K Simonds Journal: Respirology Date: 2014-03-24 Impact factor: 6.424
Authors: Ying-Jie Peng; Xiuli Zhang; Anna Gridina; Irina Chupikova; David L McCormick; Robert J Thomas; Thomas E Scammell; Gene Kim; Chirag Vasavda; Jayasri Nanduri; Ganesh K Kumar; Gregg L Semenza; Solomon H Snyder; Nanduri R Prabhakar Journal: Proc Natl Acad Sci U S A Date: 2017-01-23 Impact factor: 11.205
Authors: Rodolfo Augusto Bacelar de Athayde; José Ricardo Bandeira de Oliveira Filho; Geraldo Lorenzi Filho; Pedro Rodrigues Genta Journal: J Bras Pneumol Date: 2018 Nov-Dec Impact factor: 2.624